Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 185   

Articles published

GSK 1,553.50 -10.00 (-0.64%)
price chart
Is GlaxoSmithKline plc Just A Tracker Fund In Disguise?
I hold Glaxo, and I hold a tracker fund, the HSBC FTSE 100 Index. Both have served me well. But why hold both? After all, 4.4% of my tracker fund is actually made up of Glaxo, with its massive �80 billion market cap. The tracker gives me a dab of ...
Related articles »  
Is GlaxoSmithKline plc A Super Growth Stock?
Despite allegations of bribery in China holding shares in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) back in 2013, they have still managed to outperform the FTSE 100 over the last year.
Related articles »  
Director Deals - GlaxoSmithKline PLC (GSK)
Director Deals - GlaxoSmithKline PLC (GSK). 17 April 2014 | 17:55pm. - Andrew Witty, Chief Executive Officer, has re-invested 19,565 shares in the company on the 10th April 2014 at a price of 1581.50p.
Is GlaxoSmithKline plc An Annuity Alternative?
Annuity giant Legal & General expects the UK annuity market to halve in size following the changes announced to pension rules in last week's Budget.
Related articles »  
Glaxo Said to Fire Workers, Withhold Bonuses in China
GlaxoSmithKline Plc (GSK) fired some workers and withheld bonuses in China after a corruption investigation begun last year spurred a deeper review of employee expense claims, a person familiar with the matter said.
GlaxoSmithKline PLC (NYSE:GSK) and Mylan Inc. (NASDAQ:MYL) Leading ...  iStreetWire
GlaxoSmithKline plc Cuts Jobs in China Amid Bribery Scandal (GSK) (blog)
Related articles »  
GlaxoSmithKline plc (GSK) Charged With Bribery In Poland
British pharmaceutical giant GlaxoSmithKline plc (ADR) (NYSE:GSK) (LON:GSK) announced yesterday, April 13th, that the company is under investigation for bribery in Poland.
GSK faces bribery investigation in Poland: BBC  Reuters Canada
Related articles »  
Why GlaxoSmithKline plc's Investment Plans Should Thrust Earnings Skywards
Such measures are not guaranteed to yield results, however amd I highlighted the problems associated with drug development in my last article on the company (�2 Resounding Reasons To Sell GlaxoSmithKline�) and the impact this can have in terms of lost ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) To Investigate Bribery In Iraq
Tomahawk, WI 04/08/2014 (Basicsmedia) - British drugs maker GlaxoSmithKline plc (ADR) (NYSE:GSK) is all set to investigate bribery charges in Iraq, the company said on Sunday.
Glaxo Begins Investigating Alleged Improper Conduct in Iraq (1)  Businessweek
GSK probes possible corruption in Iraq  Seeking Alpha
Related articles »  
GlaxoSmithKline plc (ADR) (GSK): Significant Upside For The Stock
technical chart look Rick Pendergraft: Pharmaceutical giant GlaxoSmithKline plc (ADR) (NYSE:GSK) caught my attention last night as the stock has formed an island bottom.
Brand Face-Off: GlaxoSmithKline plc (ADR) vs. Merck & Co., Inc.
Pharmaceutical giants GlaxoSmithKline plc (ADR) (NYSE:GSK) and Merck & Co., Inc. (NYSE:MRK) have charted different paths during the last year.
Related articles »